compname and logo of company are phil & co, co, qor.
compname reports second quarter 2021 results.
compname reports q3 revenue of $700 million.
compname reports qtrly international & other revenue of $1.8 billion, up 12% as compared to $1 billion.
compname reports q2 adjusted ebitda 8.9 percent growth and earnings per share.
qtrly trulicity performance continues to be strong.
paraphrase:
not providing earnings guidance for fiscal year.
compname reports fourth quarter results.
q4 revenue up 30 percent to $731 million.
sebruary 2021 operating results were similar to that of q2 2021 as reported during q2 of fiscal 2021.
compname reports results for q3 of 2021, provides outlook for financial services businesses.
qtrly net sales of $2.2 billion, an increase of nearly two-thirds from year-earlier quarter.
qtrly net sales down about 30%.
quarter 2021 pharmaceutical sales rose 35%.
compname says received FDA approval for clinical value improvement treatment, with no change to its usual diabetes treatment guidelines.
